SIM
ALNA

Spark Investment Management’s Allena Pharmaceuticals ALNA Stock Holding History

Spark Investment Management’s Portfolio ALNA Stock Details ALNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-15,300
Closed -$24K – 90
2020
Q2 		$24K Hold
15,300
– – 0.09% 73
2020
Q1 		$14K Buy
+15,300
New +$30.6K 0.01% 353
2018
Q3 		– Sell
-16,000
Closed -$208K – 771
2018
Q2 		$208K Buy
+16,000
New +$231K 0.01% 554

Other funds holding ALNA

FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
TGI
TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Spark Investment Management's ALNA Position: Q3 2020 in Review

Spark Investment Management sold out of Allena Pharmaceuticals (ALNA) in Q3 2020, closing a stake of 15,300 shares — an estimated $24K sold.

Spark Investment Management first reported a position in ALNA in Q2 2018 and held it in 3 quarters. The position peaked at $208K in Q2 2018. 24 funds tracked by Wall St. Rank hold ALNA as of Q3 2020.

  • Spark Investment Management reported no remaining Allena Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Spark Investment Management sold 15,300 Allena Pharmaceuticals shares in Q3 2020, an estimated $24K.
  • Spark Investment Management first reported a position in Allena Pharmaceuticals in Q2 2018 and held it in 3 quarters.
  • Spark Investment Management's Allena Pharmaceuticals position peaked at $208K in Q2 2018.
  • 24 funds tracked by Wall St. Rank held Allena Pharmaceuticals as of Q3 2020.

Based on Spark Investment Management's 13F filing for Q3 2020, filed 12 Nov 2020.